113 related articles for article (PubMed ID: 8457326)
1. Intracellular levels and extracellular release of lysosomal enzymes from peripheral blood monocytes in pulmonary tuberculosis patients.
Jaswal S; Dhand R; Sethi AK; Kohli KK; Ganguly NK
APMIS; 1993 Jan; 101(1):50-4. PubMed ID: 8457326
[TBL] [Abstract][Full Text] [Related]
2. Elevation of plasma levels of lysosomal enzymes during treatment with rifampicin and isoniazid.
Perry W; Jenkins MV; Erooga MA; Stamp TC
Biochem Med; 1978 Oct; 20(2):153-9. PubMed ID: 32879
[No Abstract] [Full Text] [Related]
3. Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.
Newman R; Doster BE; Murray FJ; Woolpert SF
Am Rev Respir Dis; 1974 Feb; 109(2):216-32. PubMed ID: 4204541
[No Abstract] [Full Text] [Related]
4. Serum levels of soluble urokinase plasminogen activator receptor (suPAR) as a marker of tuberculosis treatment efficacy.
Indumati V; Vijay V; Krishnaswamy D; Rajeshwari V; Ramesh A; Shantala D; Shilpa A
Indian J Tuberc; 2017 Jul; 64(3):206-211. PubMed ID: 28709490
[TBL] [Abstract][Full Text] [Related]
5. [Use of rifampin and ethambutol for the treatment of pulmonary tuberculosis].
Shukiurov ShZ
Probl Tuberk; 1973; 51(12):40-3. PubMed ID: 4782102
[No Abstract] [Full Text] [Related]
6. Release of acid hydrolases in spectrum of human leprosy.
Kumar B; Jaswal S; Vaishnavi C; Thakur M; Kaur S; Ganguly NK
J Hyg Epidemiol Microbiol Immunol; 1992; 36(4):405-11. PubMed ID: 1300357
[TBL] [Abstract][Full Text] [Related]
7. Rifampicin, ethambutol, ethionamide and hydronsan in advanced pulmonary tuberculosis.
Salinger PL; Dormer BA
S Afr Med J; 1972 Mar; 46(13):354-8. PubMed ID: 5074542
[No Abstract] [Full Text] [Related]
8. Chemotherapeutic agents in pulmonary tuberculosis with special reference to isoniazid-ethambutol continuation therapy.
Lees AW
Ir J Med Sci; 1985 May; 154(5 Suppl 1):38-41. PubMed ID: 4030286
[No Abstract] [Full Text] [Related]
9. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
10. [Two cases of pulmonary tuberculosis having evolved after the first attack with triple therapy of isoniazid, rifampicin and ethambutol].
Wipf R
Rev Med Suisse Romande; 1979 Apr; 99(4):205-13. PubMed ID: 504855
[No Abstract] [Full Text] [Related]
11. The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco.
Slutkin G; Schecter GF; Hopewell PC
Am Rev Respir Dis; 1988 Dec; 138(6):1622-4. PubMed ID: 3144221
[TBL] [Abstract][Full Text] [Related]
12. A comparative trial with combinations of rifampicin, ethambutol and isoniazid (Hydronsan) in previously untreated cases of pulmonary tuberculosis.
Dormer BA; Salinger PL
S Afr Med J; 1971 Jun; 45(25):697-9. PubMed ID: 5559403
[No Abstract] [Full Text] [Related]
13. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
Chioléro R
Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
[No Abstract] [Full Text] [Related]
14. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
Lesobre R; Frey N
Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051
[No Abstract] [Full Text] [Related]
15. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
Oka S; Sasaki M; Kobayashi T; Matsuda T
Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
[No Abstract] [Full Text] [Related]
16. Monocytes in inflammatory bowel disease: monocyte and serum lysosomal enzyme activity.
Mee AS; Jewell DP
Clin Sci (Lond); 1980 Apr; 58(4):295-300. PubMed ID: 7379454
[TBL] [Abstract][Full Text] [Related]
17. [Short-term chemotherapy of pulmonary tuberculosis. Bacteriologic results].
Boulahbal F; Tazir M; Khaled S; Chaulet P; el Awadi Z
Arch Inst Pasteur Alger; 1980; 54():162-72. PubMed ID: 6765476
[No Abstract] [Full Text] [Related]
18. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
Kesztele V; Niederkofler J
Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
[No Abstract] [Full Text] [Related]
19. beta-N-acetylglucosaminidase and beta-glucuronidase activities in insulin-dependent diabetic subjects with retinopathy.
Pitkänen E; Kyllästinen M; Koivula T; Hormila P
Diabetologia; 1980 Apr; 18(4):275-8. PubMed ID: 7418953
[TBL] [Abstract][Full Text] [Related]
20. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
Research Committee of the British Thoracic Society
Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
